Terms: = Pancreatic cancer AND MLLT4, ENSG00000130396, 4301
3 results:
1. A novel scoring system predicts postsurgical survival and adjuvant chemotherapeutic benefits in patients with pancreatic adenocarcinoma: Implications for AJCC-TNM staging.
Liu L; Xu HX; He M; Wang W; Wang WQ; Wu CT; Wei RQ; Liang Y; Gao HL; Liu C; Xu J; Long J; Ni QX; Shao CH; Wang J; Yu XJ
Surgery; 2018 Jun; 163(6):1280-1294. PubMed ID: 29548773
[TBL] [Abstract] [Full Text] [Related]
2. Risk-adjusted Outcomes of Clinically Relevant pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance Evaluation.
McMillan MT; Soi S; Asbun HJ; Ball CG; Bassi C; Beane JD; Behrman SW; Berger AC; Bloomston M; Callery MP; Christein JD; Dixon E; Drebin JA; Castillo CF; Fisher WE; Fong ZV; House MG; Hughes SJ; Kent TS; Kunstman JW; Malleo G; Miller BC; Salem RR; Soares K; Valero V; Wolfgang CL; Vollmer CM
Ann Surg; 2016 Aug; 264(2):344-52. PubMed ID: 26727086
[TBL] [Abstract] [Full Text] [Related]
3. Loss of polarity protein AF6 promotes pancreatic cancer metastasis by inducing Snail expression.
Xu Y; Chang R; Peng Z; Wang Y; Ji W; Guo J; Song L; Dai C; Wei W; Wu Y; Wan X; Shao C; Zhan L
Nat Commun; 2015 May; 6():7184. PubMed ID: 26013125
[TBL] [Abstract] [Full Text] [Related]